Cooper Companies (COO) Liabilities and Shareholders Equity (2009 - 2026)
Cooper Companies' (COO) quarterly Liabilities and Shareholders Equity came in at $12.5 billion in Q2 2026, up 0.55% year-on-year from $12.4 billion in Q2 2025, and little changed quarter-over-quarter from $12.4 billion in Q1 2026.
Cooper Companies (COO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Cooper Companies' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $12.5 billion for Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 0.55% year-over-year to $12.5 billion in Q2 2026; TTM through Apr 2026 was $49.7 billion, a 1.26% increase from a year earlier, with the FY2025 full-year figure at $12.4 billion, up 0.65% from the prior year.
- Liabilities and Shareholders Equity held at $12.5 billion in Q2 2026 per COO's latest filing, from $12.4 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $12.5 billion in Q2 2026 and bottomed at $11.5 billion in Q4 2022.
- The 5-year median for Liabilities and Shareholders Equity is $12.0 billion (2024), against an average of $12.0 billion.
- Across the five-year window, Liabilities and Shareholders Equity jumped 30.72% in 2022 and fell 2.02% in 2023, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $11.5 billion in 2022, then rose by 1.45% to $11.7 billion in 2023, then gained by 5.63% to $12.3 billion in 2024, then advanced by 0.65% to $12.4 billion in 2025, then advanced by 0.71% to $12.5 billion in 2026.
- Per Business Quant, the three latest COO Liabilities and Shareholders Equity figures stand at $12.5 billion (Q2 2026), $12.4 billion (Q1 2026), and $12.4 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 19.85 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 12.48 Bn |
| Jan 31, 2026 | 12.42 Bn |
| Oct 31, 2025 | 12.39 Bn |
| Jul 31, 2025 | 12.38 Bn |
| Apr 30, 2025 | 12.41 Bn |
| Jan 31, 2025 | 12.22 Bn |
| Oct 31, 2024 | 12.32 Bn |
| Jul 31, 2024 | 12.11 Bn |
| Apr 30, 2024 | 12.05 Bn |
| Jan 31, 2024 | 12.03 Bn |
| Oct 31, 2023 | 11.66 Bn |
| Jul 31, 2023 | 11.70 Bn |
| Apr 30, 2023 | 11.54 Bn |
| Jan 31, 2023 | 11.56 Bn |
| Oct 31, 2022 | 11.49 Bn |
| Jul 31, 2022 | 11.55 Bn |
| Apr 30, 2022 | 11.78 Bn |
| Jan 31, 2022 | 11.66 Bn |
| Oct 31, 2021 | 9.61 Bn |
| Jul 31, 2021 | 9.61 Bn |